| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Oyler John is a Chief Executive Officer at BeOne Medicines Ltd.. Recent SEC Form 4 filings include 0 buys and 130 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 92,177 | $237.06 | $21,851,789.34 | -26.2% | |
| Aug 14, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 42,968 | $212.71 | $9,139,562.00 | -27.6% | |
| Aug 5, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 17,254 | $223.27 | $3,852,273.15 | -19.9% | |
| Aug 4, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 40,559 | $221.27 | $8,974,526.31 | -17.2% | |
| Jul 22, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 27,748 | $238.34 | $6,613,503.28 | -25.4% | |
| Jul 21, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 55,175 | $251.84 | $13,895,479.20 | -23.0% | |
| Jul 8, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 53,914 | $199.12 | $10,735,455.18 | -28.7% | |
| Jul 1, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 5,251 | $191.85 | $1,007,390.65 | -63.9% | |
| Jun 24, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 39,732 | $185.90 | $7,385,983.11 | -11.7% | |
| Jun 10, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 900 | $175.07 | $157,563.00 | -100% |